The Column Group announces the hiring of Dr. Arnav Mehta. Previously, Dr. Mehta was an Entrepreneur-in-Residence at Third Rock Ventures, a gastrointestinal oncologist at the Massachusetts General Hospital Cancer Center and a physician scientist running a hybrid computational and experimental research group at the Broad Institute. At the Massachusetts General Hospital, Dr. Mehta led a translational program focused on gastrointestinal tumor immunology leveraging single cell and spatial transcriptomics of patient samples and developing computational methods for the analyses of these data. At the Broad Institute, Dr. Mehta ran a basic research program focused on pancreatic cancer plasticity using functional genomics, lineage tracing and image-based screening technologies. At Third Rock Ventures, Dr. Mehta held various clinical, translational and scientific roles as he helped conceive of and build Abata Therapeutics, and later Asher Biotherapeutics and Clasp Therapeutics, as a founding team member through launch.
